Circulating non-hematological cells during cardiopulmonary bypass: new findings in cardiac surgery procedures.

about

Circulating non-hematological cells during cardiopulmonary bypass: new findings in cardiac surgery procedures.

Item

http://www.wikidata.org/entity/Q53141309

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Circulating non-hematological ...... in cardiac surgery procedures.

@en

Circulating non-hematological ...... in cardiac surgery procedures.

@nl

type

Item

label

Circulating non-hematological ...... in cardiac surgery procedures.

@en

Circulating non-hematological ...... in cardiac surgery procedures.

@nl

prefLabel

Circulating non-hematological ...... in cardiac surgery procedures.

@en

Circulating non-hematological ...... in cardiac surgery procedures.

@nl

P1476

Circulating non-hematological ...... in cardiac surgery procedures

@en

P2093

Antonia Rizzuto

http://www.w3.org/2001/XMLSchema#string

Carmelo Dominici

http://www.w3.org/2001/XMLSchema#string

Caterina Camastra

http://www.w3.org/2001/XMLSchema#string

Chiara Mignogna

http://www.w3.org/2001/XMLSchema#string

Gianluca Santise

http://www.w3.org/2001/XMLSchema#string

Giuseppe Donato

http://www.w3.org/2001/XMLSchema#string

Giuseppe Viglietto

http://www.w3.org/2001/XMLSchema#string

Pio Zeppa

http://www.w3.org/2001/XMLSchema#string

Tullio Barni

http://www.w3.org/2001/XMLSchema#string

P2860

TEG and ROTEM: technology and clinical applications

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions.

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.

Reduced 30-day mortality in men after elective coronary artery bypass surgery with minimized extracorporeal circulation-a propensity score analysis.

Considerations in the development of circulating tumor cell technology for clinical use

The inflammatory response to miniaturised extracorporeal circulation: a review of the literature.

The "benefits" of the mini-extracorporeal circulation in the minimal invasive cardiac surgery era.

Overcoming Challenges in the Management of Critical Events During Cardiopulmonary Bypass.

Pathophysiology of Cardiopulmonary Bypass: Current Strategies for the Prevention and Treatment of Anemia, Coagulopathy, and Organ Dysfunction.

P304

584-592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0267659116638916

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniele Maselli

Anna Di Vito

Cinzia Marinaro

P577

2016-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299345591

http://www.w3.org/2001/XMLSchema#string

P698

27000150

http://www.w3.org/2001/XMLSchema#string